Suspected side effects from any medicine can also be reported directly via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk
It is studied in animal models for its reported effects on the nitric-oxide (NO) system, angiogenic signaling, and connective-tissue repair, and is supplied to qualified laboratories as a lyophilized reference peptide for benchtop research only
Microdosing is entirely off-label, as there is no set dosing for it
If you want updates, follow peer-reviewed journals or clinical trial registries for clear human data
However, the FAERS (FDA Adverse Event Reporting System) received reports of alopecia or hair loss in people taking semaglutide and other GLP-1 medications like tirzepatide (Mounjaro, Zepbound)
For mild reactions (redness, itching, small bruises), yes